Table 1.
Patient characteristics
| Variable | All patients | |
|---|---|---|
| (n = 179) | ||
| General | Female | 93 (52%) |
| Age (years) | 71.5 (65–78) | |
| BMI (kg/m2) | 26.1 (23.4–29.6) | |
| Primary malignancy | Hematologic malignancies | 32 (18%) |
| Lower gastrointestinal cancers | 27 (15%) | |
| Breast cancer | 26 (15%) | |
| Lung cancers | 24 (13%) | |
| Skin cancers and sarcomas | 16 (9%) | |
| Hepatobiliary-pancreatic cancers | 14 (8%) | |
| Gynecological cancers | 13 (7%) | |
| Genitourinary cancers | 10 (6%) | |
| Upper gastrointestinal cancers | 8 (5%) | |
| Head and neck cancers | 4 (2%) | |
| Others | 5 (3%) | |
| PET-CT indication | Staging | 36 (20%) |
| Monitor response to therapy | 70 (39%) | |
| Recurrence detection | 20 (11%) | |
| Follow-up (with NED) | 53 (30%) | |
| Recent therapy | Any systemic anti-cancer therapy | 70 (39%) |
| Chemotherapy | 38 (21%) | |
| Biologic therapy | 33 (18%) | |
| Immunotherapy | 13 (7%) |
Categorical variables are reported as frequency and percentage. Continuous variables are reported as median and IQR. BMI, body mass index; NED, no evidence of disease